The surface antigen P.69/pertactin of Bordetella pertussis has been expressed using the polyhedron promoter of baculovirus in cultured insect cells. Either full-length or truncated prn DNA was used to express P.69 pertactin. The full-length gene gave rise to low levels of P.93 precursor protein, some of which was processed to P.69. The shortened prn expressed P.69 pertactin directly at levels up to 3.5 mg per litre. P.69 vaccinated animals were protected against aerosol challenge with virulent B. pertussis bacteria
Acellular vaccines against Bordetella pertussis were introduced in Australia in 1997. By 2000, these...
AbstractPertussis is a serious infectious disease of the respiratory tract caused by the gram-negati...
Whooping cough, an acute respiratory disease affecting over sixty million infants, can be prevented ...
The prn gene encoding the 68 kDa protective outer-membrane protein of Bordetella bronchiseptica (P.6...
The mature pertactin protein (P.69) of Bordetella pertussis can be isolated from the bacterial cell ...
The immunogenicity of recombinant (r-) pertactin was examined. Parenteral immunization of mice with ...
The P.69 Bordetella pertussis protective antigen was expressed by use of the trc promoter from the c...
A new generation of whooping-cough vaccines contain P.69 pertactin, a surface-exposed domain of an o...
A new generation of whooping-cough vaccines contain P.69 pertactin, a surface-exposed domain of an o...
The role of the Bordetella pertussis P.69/pertactin protein in mammalian cell adhesion and invasion ...
The role of the Bordetella pertussis P.69/pertactin protein in mammalian cell adhesion and invasion ...
Pertussis is a highly contagious infectious disease of the respiratory tract which is caused by Bord...
Acellular whooping cough vaccines are based on pertussis toxoid but their effectiveness may be incre...
Pertactin (PRN) is an autotransporter protein produced by all members of the Bordetella bronchisepti...
A 69-kDa protein has been identified on the surface of the Gram-negative pathogen Bordetella pertuss...
Acellular vaccines against Bordetella pertussis were introduced in Australia in 1997. By 2000, these...
AbstractPertussis is a serious infectious disease of the respiratory tract caused by the gram-negati...
Whooping cough, an acute respiratory disease affecting over sixty million infants, can be prevented ...
The prn gene encoding the 68 kDa protective outer-membrane protein of Bordetella bronchiseptica (P.6...
The mature pertactin protein (P.69) of Bordetella pertussis can be isolated from the bacterial cell ...
The immunogenicity of recombinant (r-) pertactin was examined. Parenteral immunization of mice with ...
The P.69 Bordetella pertussis protective antigen was expressed by use of the trc promoter from the c...
A new generation of whooping-cough vaccines contain P.69 pertactin, a surface-exposed domain of an o...
A new generation of whooping-cough vaccines contain P.69 pertactin, a surface-exposed domain of an o...
The role of the Bordetella pertussis P.69/pertactin protein in mammalian cell adhesion and invasion ...
The role of the Bordetella pertussis P.69/pertactin protein in mammalian cell adhesion and invasion ...
Pertussis is a highly contagious infectious disease of the respiratory tract which is caused by Bord...
Acellular whooping cough vaccines are based on pertussis toxoid but their effectiveness may be incre...
Pertactin (PRN) is an autotransporter protein produced by all members of the Bordetella bronchisepti...
A 69-kDa protein has been identified on the surface of the Gram-negative pathogen Bordetella pertuss...
Acellular vaccines against Bordetella pertussis were introduced in Australia in 1997. By 2000, these...
AbstractPertussis is a serious infectious disease of the respiratory tract caused by the gram-negati...
Whooping cough, an acute respiratory disease affecting over sixty million infants, can be prevented ...